1/24/23 - Benefits Pro

Horizon’s Joel White on the Impact 2022 had on Healthcare

 Read More
1/23/23 - Inside Health Policy

White House Reviews CMS Plan For Drug Pricing Demos; CMS, Drug Makers To Meet Second Time On IRA

 Read More
1/3/23 - National Review

Horizon’s Research Highlighted in Inflation Reduction Act Reform Article

 Read More
11/15/22 - Inside Health Policy

Horizon’s Joel White Talks to Inside Health Policy about End-of-Year Medicaid Priorities

 Read More
10/15/22 - The Hill

HGA’s Joel White on Drug Pricing

 Read More
10/6/22 - Bloomberg Law

Horizon’s Brett Meeks Weighs In on NIH Director Appointment

 Read More
8/5/22 - The New York Times

HGA’s CEO Discusses Drug Costs with The New York Times

 Read More
5/23/22 - Bloomberg Government

Horizon Named a Top-Performing Lobbying Firm

 Read More
12/2/21 - WSJ Opinion

HGA President Joel White WSJ Op-Ed

 Read More
11/24/21 - Real Clear Health

HGA’s President Real Clear Health Op-Ed: “Businesses Are United Against the Attack on Drug Innovation”

 Read More
5/6/21 - NA

HGA President Testifies to House Ways and Means Committee re: Telehealth

 Read More
4/16/21 - FORTUNE

HGA President joins Fortune Podcast: The idea of a COVID-19 vaccine passports raises privacy concerns

 Read More

Search Horizon Government Affairs